Difene 100 mg Dual Release Capsules
Authorisation PA2256/001/004 · Glenwood GmbH
- Licence holder
- Glenwood GmbH (all products →)
- Active substance
- Diclofenac sodium
- Clinical trials
- 10 clinical trials →
- Dosage form
- Modified-release capsule, hard
- Route of administration
- Oral use
- ATC codes
- M01AB, M01AB05
- First authorised
- 30/05/1997
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Diclofenac sodium: supply and approvals
34 authorised products on the HPRA list contain Diclofenac sodium. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 20 Nov 2026)
- US shortage (FDA)
- Diclofenac Sodium Tablet, Delayed Release: resolved, updated 13 Aug 2026
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 20 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 29 years (since 30 May 1997). The HPRA list marks it as marketed in Ireland.
Other medicines with Diclofenac sodium in Ireland
31 other products on the HPRA list contain Diclofenac sodium, from 12 licence holders; 17 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Arthrotec 50 modified-release tablets | Pfizer Healthcare Ireland Unlimited Company | National authorisation (PA) | Marketed |
| Arthrotec 75 modified-release tablets | Pfizer Healthcare Ireland Unlimited Company | National authorisation (PA) | Marketed |
| Diclac 1% w/w Gel | Rowex Limited, | National authorisation (PA) | Marketed |
| Diclac 100mg Suppositories | Rowex Limited, | National authorisation (PA) | Marketed |
| Diclac 50 mg Gastro-resistant Tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Diclac 75 mg Prolonged-release Tablet | Rowex Limited, | National authorisation (PA) | Marketed |
| Diclac Relief 1% w/w Gel | Rowex Limited, | National authorisation (PA) | Marketed |
| Diclac Retard 100 mg Prolonged-release Tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Difene 1% w/w Gel | Glenwood GmbH | National authorisation (PA) | Marketed |
| Difene 25mg Capsules | Glenwood GmbH | National authorisation (PA) | Marketed |
| Difene 50mg Capsules | Glenwood GmbH | National authorisation (PA) | Marketed |
| Difene 75 mg Dual Release Capsules | Glenwood GmbH | National authorisation (PA) | Marketed |
Other substances in ATC group M01AB
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 4 other active substances share the group M01AB with this product:
Misoprostol (5) · Diclofenac potassium (2) · Lactose monohydrate (1) · Aceclofenac (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
Glenwood GmbH holds 14 products on the HPRA list, with 4 different active substances; 12 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 21 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.